A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2006
11/14/2006	US7135453 Reagents and methods for smooth muscle therapies
11/14/2006	US7135320 Adaptor protein FRS2 and related products and methods
11/14/2006	US7135279 4-alpha glucotransferases; enzymes inhibitors; enantimorphs; adrenergic blocking agents; proteases; superoxide dismutases; carbonic anhydrases
11/14/2006	US7135195 Colorless antimicrobioal aqueous suspension of colloidal silver particles having an interior of elemental silver and a surface of silver oxide of given particle diameters; antiseptic and surface disinfectant and for treatment of viral, fungal, and bacterial infections
11/14/2006	CA2340320C Use of an angiogenic factor for the treatment of microascular angiopathies
11/14/2006	CA2214072C Benzo [b] thiophene compounds, intermediates, processes, compositions, and methods
11/14/2006	CA2128955C Tricyclic benzazepine vasopressin antagonists
11/09/2006	WO2006118341A1 Novel lactam compound
11/09/2006	WO2006118328A1 Degranulation inhibitor
11/09/2006	WO2006118313A1 Novel polypeptide and use thereof
11/09/2006	WO2006118299A1 Gpcr inhibitor
11/09/2006	WO2006118256A1 2-aminoquinazoline derivatives
11/09/2006	WO2006118131A1 Peptide having anti-anxiety effect and method for screening thereof
11/09/2006	WO2006118087A1 Crystal of hydroxynorephedrin derivative hydrochloride 1/4 hydrate
11/09/2006	WO2006117760A1 Adrenergic receptor antagonists
11/09/2006	WO2006017650A3 Iron chelators for treating radiocontrast-associated renal dysfunction
11/09/2006	WO2005089711A3 Pharmaceutical formulation containing unmilled flutamide
11/09/2006	US20060252814 Formulation comprising a betablocker and optionally a cholestrol-lowering agent
11/09/2006	US20060252806 synergistic use of angiotensin II receptor antagonist like (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazol-5-carboxylate with the calcium channel blockers; calcium channel blockers containing 1,4-dihydropyridine group
11/09/2006	US20060252805 synergistic use of angiotensin II receptor antagonist like (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazol-5-carboxylate with the calcium channel blockers; calcium channel blockers containing 1,4-dihydropyridine group
11/09/2006	US20060252799 Benzo (F) insoindol derivatives and their use as EP4 receptor ligands
11/09/2006	US20060252797 Receptor regulator
11/09/2006	US20060252780 Fused pyrimidine derivatives
11/09/2006	US20060252730 Adenosine receptor antagonists and methods of making and using the same
11/09/2006	US20060252104 Screening for a compound to inhibit the urge for urinary incontinence by detecting activation of KCNQ protein in the host cell; measuring the membrane potential of the host cell and selecting the compound whose presence causes hyperpolarization in themembrane potential of the host cell
11/09/2006	US20060251660 Antibodies to human IL-1beta
11/09/2006	US20060251651 Antagonist and agonist which bind to a strong binding site of chemokine receptor
11/09/2006	CA2607506A1 Novel lactam compound
11/09/2006	CA2606177A1 Novel polypeptide and use thereof
11/09/2006	CA2606162A1 Peptide having antianxiety activity and screening method therefor
11/09/2006	CA2605298A1 Crystal of hydroxynorephedrin derivative hydrochloride 1/4 hydrate
11/08/2006	EP1719763A1 Novel pyridine derivative and pyrimidine derivative (2)
11/08/2006	EP1719762A1 Novel pyridine derivative and pyrimidine derivative (1)
11/08/2006	EP1719757A1 Bicyclo derivative
11/08/2006	EP1719506A1 Gene expression controlling agent
11/08/2006	EP1718635A1 Piperidinyl targeting compounds that selectively bind integrins
11/08/2006	EP1361882B1 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
11/08/2006	EP1296716B1 Use of a beta-blocker for the treatment of atherosclerosis
11/08/2006	EP1294691B1 Serine protease inhibitors
11/08/2006	EP1227791B1 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition
11/08/2006	EP1080074B1 Heterocyclic substituted amides, their production and their use
11/08/2006	CN1860228A Staple type oligonucleotide and drug comprising the same
11/08/2006	CN1858216A Gamma-linolenic acid dry microbial powder enriched with organic celenium and its producing process
11/08/2006	CN1858191A Kidney tonifying health wine
11/08/2006	CN1857647A Sanjin dripping pill and its preparing method
11/08/2006	CN1857630A Proteinuria treating Chinese medicine and its preparing method and use
11/08/2006	CN1857629A Hematuria treating Chinese medicine and its preparing method and use
11/08/2006	CN1857621A Capsule for treating acute and chronic prostatitis and its preparing process
11/08/2006	CN1857562A Kidney invigorating hair restorer preparation its preparing process
11/08/2006	CN1857549A Medicine for treating renal calculus
11/08/2006	CN1857537A Compound Chinese medicine preparation for eliminating damp and heat and dissipating mass and its preparing method
11/08/2006	CN1857523A Preparing process of urethra inflammation treating capsule
11/08/2006	CN1857487A Medicine for treating male's renal insufficiency and its preparing method
11/08/2006	CN1857471A Tribuloside composition preparing and its preparing process
11/08/2006	CN1857464A Chinese medicine composition for treating renal failure and its preparing method and use
11/08/2006	CN1857448A Qianlieping preparation for treating prostatosis and its preparing process
11/08/2006	CN1857394A Medicine composition of effective parts for compound Tongmai Chinese medicine oral liquid and its preparing method
11/08/2006	CN1857366A Medicinal wine and its preparing method
11/08/2006	CN1857361A Medicine for treating prostatosis and its preparing method and application
11/08/2006	CN1857337A Use of patrinia herb and its extract in preparing medicine for treating prostatic hyperplasia
11/08/2006	CN1857333A Aweto bolus and its preparing method
11/08/2006	CN1857319A Preparing method of scalded leech medicine granule
11/08/2006	CN1857238A Emodin emulsion for injection and its preparing process
11/08/2006	CN1284088C 访问控制系统 Access Control System
11/08/2006	CN1283664C Erythropoietin conjugate
11/08/2006	CN1283662C Antagonistic anti-hFAS ligand human antibodies and fragments thereof
11/08/2006	CN1283656C C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
11/08/2006	CN1283610C Ketone compounds and compositions for cholesterol management and related uses
11/08/2006	CN1283286C Medicinal spirit for nourishing liver and kidney
11/08/2006	CN1283268C Compound dandelion freeze dried powder injection and its preparation method
11/08/2006	CN1283250C Stabilized formulations of 6-hydroxy-3-(4-[piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof
11/07/2006	US7132551 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimers, Parkinsons, Lesche-Nyhane, Wilsons, and Tourettes syndrome
11/07/2006	US7132547 Preventives/remedies for urinary disturbance
11/07/2006	US7132457 Adamantane derivatives
11/07/2006	US7132443 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
11/07/2006	US7132439 Bis-benzimidazoles and related compounds as potassium channel modulators
11/07/2006	US7132430 Treatment of cardiovascular and related pathologies
11/07/2006	US7132418 For therapy and prophylaxis of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis, immunomediated inflammatory disorders, such as rheumatoid arthritis, conjunctivitis, psoriasis
11/07/2006	US7132417 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
11/07/2006	US7132408 Composition and method for inhibiting platelet aggregation
11/07/2006	US7132261 Nuclear localization peptides for estrogens; antitumor agents; anticarcinogenic agents; hormone replacement therapy; bradycardial agents
11/07/2006	CA2416879C Methods of treating cancer and the pain associated therewith using endothelin antagonists
11/02/2006	WO2006116401A1 C-5 substituted quinazolinone derivatives as selective estrogen receptor beta modulators
11/02/2006	WO2006116302A2 High-potency botulinum toxin formulations
11/02/2006	WO2006116169A2 Methods for modulating bladder function
11/02/2006	WO2006115286A1 Piperidine derivatives, crystal, process for producing the same, and use as tachikinin receptor antagonists
11/02/2006	WO2006115285A1 Pharmaceutical composition
11/02/2006	WO2006115274A1 Myeloerythroid progenitor differentiation inducer
11/02/2006	WO2006115247A1 HIGHLY SELECTIVE Rho-KINASE INHIBITOR
11/02/2006	WO2006115245A1 4-ethynylisoquinoline derivative and pharmaceutical preparation comprising the same
11/02/2006	WO2006115244A1 4-bromoisoquinoline derivative and pharmaceutical preparation comprising the same
11/02/2006	WO2006115188A1 Heterocyclic compound
11/02/2006	WO2006115154A1 Crystal polymorphism of 4’-{2-[(1s,2r)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethylamino]ethoxy}-3-isopropyl-3’,5’-dimethylbiphenylcarboxylic acid hydrochloride
11/02/2006	WO2006115137A1 2-aminobenzimidazole derivative and use of the same for medical purposes
11/02/2006	WO2006114264A1 Acetylene derivatives
11/02/2006	WO2006079559A3 The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
11/02/2006	US20060247290 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/02/2006	US20060247261 Pyrimidine compounds
11/02/2006	US20060247260 Bis (hetero) aryl carboxamide derivatives for use as PG12 antagonists
11/02/2006	US20060247233 Thiazoles inhibitors of the alk-5 receptor

1 ... 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 ... 562